Docgo Inc. (DCGO) Stock Price & Analysis
Docgo Inc. (DCGO) fell 11.07% to USD 0.6 as of July 25, 2026 at 05:51 UTC, according to Nexqual real-time market data.
DCGO last closed at USD 0.67; the session ranged USD 0.59–0.67 on volume of 789,829 shares. Market capitalization is $58.85M, with a 52-week range of USD 0.45–1.78 (NCM). Source: Nexqual, July 25, 2026 at 05:51 UTC.
Key Statistics (as of July 25, 2026 at 05:51 UTC)
| Price | USD 0.6 |
|---|---|
| Change | ▼ 11.07% (down) |
| Previous Close | USD 0.67 |
| Open | USD 0.66 |
| Day Range | USD 0.59 – 0.67 |
| 52-Week Range | USD 0.45 – 1.78 |
| Volume | 789,829 shares |
| Market Cap | $58.85M |
| Exchange | NCM |
Technical Analysis (DCGO)
Nexqual's technical model rates DCGO "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 05:51 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.42 (neutral) |
| vs SMA50 | Above (USD 0.59) |
| MACD | 0.02 (positive) |
Analyst Ratings (DCGO)
Wall Street analysts rate DCGO "Buy" based on 4 analysts, with a mean price target of USD 1.88 (range USD 1–3), per Nexqual as of July 25, 2026 at 05:51 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 1.88 |
| High Target | USD 3 |
| Low Target | USD 1 |
| Buy / Hold / Sell | 2 / 3 / 0 |
Earnings (DCGO)
| Next Earnings Date | 2026-08-06 |
|---|---|
| EPS Estimate | USD -0.15 |
| Revenue Estimate | $75.57M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.33 vs est -0.06 ▼ miss |
| 2025-12-31 | USD -1.68 vs est -0.34 ▼ miss |
| 2025-09-30 | USD -0.25 vs est -0.4 ▲ beat |
| 2025-06-30 | USD -0.21 vs est -0.23 ▲ beat |
Source: Nexqual, July 25, 2026 at 05:51 UTC.
Financials & Fundamentals (DCGO)
| Total Revenue | $301.71M |
|---|---|
| Revenue Growth (YoY) | -21.30% |
| Gross Margin | +30.42% |
| Operating Margin | -24.77% |
| Profit Margin | -62.23% |
| ROE | -97.78% |
| Debt / Equity | 25.63 |
| Current Ratio | 1.79 |
| Total Cash | $35.68M |
| Total Debt | $28.51M |
| Free Cash Flow | $43.99M |
Source: Nexqual, July 25, 2026 at 05:51 UTC.
Financial Health Score (DCGO)
Nexqual rates Docgo Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 05:51 UTC.
| Growth | Critical — Revenue -48% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Gross margin 30%, operating -25% |
| Balance Sheet | Strong — $36M cash vs $29M debt, net cash position |
| Cash Flow | Solid — FCF $44M, 14% margin |
| Efficiency | Critical — ROE -98%, ROA -18.3% |
Ownership (DCGO)
| Insider Ownership | +3.07% |
|---|---|
| Institutional Ownership | +43.63% |
| Shares Outstanding | 98.78M |
| Float | 95.97M |
| Short % of Float | +2.40% |
Source: Nexqual, July 25, 2026 at 05:51 UTC.
Leadership (DCGO)
Docgo Inc. is led by Lee Bienstock (age 40), CEO & Director, per Nexqual as of July 25, 2026 at 05:51 UTC.
| CEO & Director | Lee Bienstock (age 40) |
|---|---|
| Treasurer & CFO | Norman Rosenberg (age 55) |
| General Counsel, Secretary & Director | Ely D. Tendler (age 57) |
| Vice President of Investor Relations | Mike Cole |
| Vice President of Human Resources | Rosemarie Milano |
Major Backers & Investors (DCGO)
Notable institutional backers of Docgo Inc. include P.A.W. Capital Corp, Knott David M., Jr., Citadel, according to Nexqual as of July 25, 2026 at 05:51 UTC.
Active Investors
| Investor | Stake |
|---|---|
| P.A.W. Capital Corp | 3.04% |
| Knott David M., Jr. | 2.7% |
| Citadel | 2.53% |
| S Squared Technology, LLC | 2.08% |
| Acadian Asset Management. LLC | 1.54% |
| Renaissance Technologies | 1.53% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 9.47% |
| Vanguard Group | 8.12% |
| Geode Capital | 2.44% |
| State Street | 1.99% |
Source: Nexqual, July 25, 2026 at 05:51 UTC.
From Docgo Inc.'s Latest SEC 10-K Filing (filed 2026-03-16)
Key Strengths & Strategy (as disclosed to the SEC)
- We partner with leading national health systems, insurance carriers, private organizations and employers, state and local governments and managed care organizations to provide our Mobile Health Services, including NYC Health + Hospitals, the U.S.
- Every vehicle in our fleet is equipped with our proprietary technology platform, which is integrated with some of the nation's largest electronic medical record ("EMR") systems.
- It contains operating expenses such as information technology costs, certain insurance costs, the compensation costs of senior and executive leadership, and software development costs for our proprietary technology platform.
- Our proprietary platform, mobile application and associated software code and firmware are protected as trade secrets and our confidential information, as appropriate.
Partnerships
- We often provide our services in collaboration with leading healthcare organizations via long-term relationships that are intended to provide efficient and strategic capital deployment opportunities that can drive meaningful revenue and create significant growth.
- Under the CMPL, physicians who pay or accept kickbacks also face penalties of up to $50,000 per kickback plus three times the amount of the kickback at issue.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SEAT | Vivid Seats Inc. | USD 7.01 | ▲ 0.14% |
| HLLY | Holley Inc. | USD 2.61 | ▲ 2.35% |
| MYPS | PLAYSTUDIOS, Inc. | USD 0.62 | ▼ 9.54% |
| MXCT | MaxCyte, Inc. | USD 1.08 | ▼ 5.26% |
| HLMN | Hillman Solutions Corp. | USD 7.97 | ▼ 0.38% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:51 UTC. This page is informational and not investment advice.